Document ID: chunk:federal_register_of_legislation:F2025L00142:front:0:p1
Version: federal_register_of_legislation:F2025L00142
Segment Type: other
Provision Reference: 
Character Range: 0–3491

Statement of Principles
concerning
MALIGNANT NEOPLASM OF THE URETHRA
 (Balance of Probabilities)
(No. 20 of 2025)
The Repatriation Medical Authority determines the following Statement of Principles under subsection 196B(3) of the Veterans' Entitlements Act 1986.

Dated 18 February 2025.

Professor Terence Campbell AM
Chairperson
by and on behalf of
The Repatriation Medical Authority

Contents
1 Name
2 Commencement
3 Authority
4 Repeal
5 Application
6 Definitions
7 Kind of injury, disease or death to which this Statement of Principles relates
8 Basis for determining the factors
9 Factors that must exist
10 Relationship to service
11 Factors referring to an injury or disease covered by another Statement of Principles
Schedule 1 - Dictionary
1 Definitions

 1.                Name
This is the Statement of Principles concerning malignant neoplasm of the urethra (Balance of Probabilities) (No. 20 of 2025).
 1.                Commencement
              This instrument commences on 25 March 2025.
 1.                Authority
This instrument is made under subsection 196B(3) of the Veterans' Entitlements Act 1986.
 1.                Repeal
The Statement of Principles concerning malignant neoplasm of the urethra (Balance of Probabilities) (No. 50 of 2016) (Federal Register of Legislation No. F2016L00581) made under subsection 196B(3) of the VEA is repealed.
 1.                Application
This instrument applies to a claim to which section 120B of the VEA or section 339 of the Military Rehabilitation and Compensation Act 2004 applies.
 1.                Definitions
The terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument.
 1.                Kind of injury, disease or death to which this Statement of Principles relates
        1.           This Statement of Principles is about malignant neoplasm of the urethra and death from malignant neoplasm of the urethra.
Meaning of malignant neoplasm of the urethra
 1.           For the purposes of this Statement of Principles, malignant neoplasm of the urethra:
         1.           means a primary malignant neoplasm arising from the epithelial cells lining the urethra; and
         2.           includes:
                 1.             adenocarcinoma of the urethra;
                 2.          carcinoma in situ of the urethra;
                 3.        clear cell adenocarcinoma of the urethra;
                 4.         malignant neoplasms of the urethral accessory glands;
                 5.           squamous cell carcinoma of the urethra;
                 6.         urothelial cell carcinoma of the urethra;
                 7.      urethral diverticular carcinoma;
                 8.    primary melanoma of the urethra; and
         3.           excludes:
                 1.             carcinoid tumours;
                 2.          haematolymphoid tumours including non-Hodgkin lymphoma and Hodgkin lymphoma;
                 3.        malignant neoplasm of the urethral orifice of the bladder;
                 4.         metastatic cancer from other primary sites including bladder, ureter and renal pelvis;
                 5.           soft tissue sarcoma.
 2.           While malignant neoplasm of the urethra attracts ICD‑10‑AM code C68.0 and C68.1, in applying this Statement of Principles the meaning of malignant neoplasm of the urethra is that given in subsection (2).
 3.           For subsection (3), a reference to an ICD-10-AM code is